ID   LECS1_MYTVI             Reviewed;         129 AA.
AC   A0A646QV53;
DT   29-SEP-2021, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   03-AUG-2022, entry version 9.
DE   RecName: Full=GM1b/asialo-GM1 oligosaccharide-binding R-type lectin {ECO:0000303|PubMed:31769916, ECO:0000303|PubMed:33328520};
DE   AltName: Full=R-type lectin 1 {ECO:0000312|EMBL:QBM06340.1};
DE   AltName: Full=SeviL {ECO:0000303|PubMed:31769916, ECO:0000303|PubMed:33328520};
DE   AltName: Full=SeviL-1 {ECO:0000303|PubMed:31769916};
OS   Mytilisepta virgata (Purplish bifurcate mussel) (Tichogonia virgata).
OC   Eukaryota; Metazoa; Spiralia; Lophotrochozoa; Mollusca; Bivalvia;
OC   Autobranchia; Pteriomorphia; Mytilida; Mytiloidea; Mytilidae;
OC   Brachidontinae; Mytilisepta.
OX   NCBI_TaxID=2547956;
RN   [1] {ECO:0000312|EMBL:QBM06340.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 104-115, FUNCTION, ACTIVITY
RP   REGULATION, SUBUNIT, TISSUE SPECIFICITY, BIOTECHNOLOGY, AND 3D-STRUCTURE
RP   MODELING.
RX   PubMed=31769916; DOI=10.1111/febs.15154;
RA   Fujii Y., Gerdol M., Kawsar S.M.A., Hasan I., Spazzali F., Yoshida T.,
RA   Ogawa Y., Rajia S., Kamata K., Koide Y., Sugawara S., Hosono M.,
RA   Tame J.R.H., Fujita H., Pallavicini A., Ozeki Y.;
RT   "A GM1b/asialo-GM1 oligosaccharide-binding R-type lectin from purplish
RT   bifurcate mussels Mytilisepta virgata and its effect on MAP kinases.";
RL   FEBS J. 287:2612-2630(2019).
RN   [2] {ECO:0000312|PDB:6LF1, ECO:0000312|PDB:6LF2}
RP   X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) AND IN COMPLEX WITH OLIGOSACCHARIDE
RP   OF ASIALO-GM1, FUNCTION, ACTIVITY REGULATION, SUBUNIT, BIOTECHNOLOGY, AND
RP   MUTAGENESIS OF GLN-12; ASP-39 AND PHE-126.
RX   PubMed=33328520; DOI=10.1038/s41598-020-78926-7;
RA   Kamata K., Mizutani K., Takahashi K., Marchetti R., Silipo A., Addy C.,
RA   Park S.Y., Fujii Y., Fujita H., Konuma T., Ikegami T., Ozeki Y.,
RA   Tame J.R.H.;
RT   "The structure of SeviL, a GM1b/asialo-GM1 binding R-type lectin from the
RT   mussel Mytilisepta virgata.";
RL   Sci. Rep. 10:22102-22102(2020).
CC   -!- FUNCTION: Galbeta1-3GalNAcbeta1-4Galbeta1-4Glc oligosaccharide-binding
CC       lectin. Binds strongly to the oligosaccharides of ganglioside GM1b and
CC       to a lesser extent its precursor asialo-GM1 (PubMed:31769916,
CC       PubMed:33328520). Binds weakly to asialo-GM2 oligosaccharide and to the
CC       glycan moiety of globo-series stage-specific embryonal antigen 4 (SSEA-
CC       4) hexaose (PubMed:31769916). Binds galactose, N-acetylgalactose and
CC       lactose. Does not bind GM1 (PubMed:33328520). Does not bind to Gal-
CC       beta1,3-GalNAc (Thomsen-Friedenreich antigen), the oligosaccharide of
CC       GM1a ganglioside or SSEA-4 tetraose. Does not bind to N-glycans, O-
CC       glycans or glycosaminoglycans of glycoproteins. Does not bind Lewis
CC       glycans, derivatives of lactose or N-acetyllactosamine or blood group
CC       (ABH-type) oligosaccharides (PubMed:31769916). Does not bind glucose
CC       (PubMed:33328520). Has hemagglutination activity towards rabbit
CC       erythrocytes (PubMed:31769916, PubMed:33328520). Displays cytotoxic
CC       effects against various cultured cell lines including human breast
CC       (MCF7), cervical (HeLa) and colon cancer (Caco2) cell lines, as well as
CC       dog kidney (MDCK) cell line that express asialo-GM1 oligosaccharide at
CC       their cell surface. Shows dose- and time-dependent activation of
CC       MKK3/6, ERK1/2 and p38 MAPK, as well as caspase-3/9 in HeLa cervical
CC       cancer cells. No cytotoxic effect on BT474 human breast cancer cell
CC       line. May be involved in recognition of glycans found on parasitic or
CC       symbiotic microorganisms (PubMed:31769916).
CC       {ECO:0000269|PubMed:31769916, ECO:0000269|PubMed:33328520}.
CC   -!- ACTIVITY REGULATION: Hemagglutination activity requires divalent
CC       cations such as Ca(2+) (PubMed:31769916, PubMed:33328520).
CC       Hemagglutination activity is weakly inhibited by monosaccharides such
CC       as D-Gal (25 mM), D-GalNAc (25 mM) and D-Fuc (25 mM) and by
CC       disaccharides such as melibiose (25 mM) and lactose (25 mM).
CC       Hemagglutination activity is inhibited by bovine submaxillary mucin,
CC       but not by porcine stomach mucin or fetuin (PubMed:31769916).
CC       {ECO:0000269|PubMed:31769916, ECO:0000269|PubMed:33328520}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:31769916,
CC       ECO:0000269|PubMed:33328520}.
CC   -!- TISSUE SPECIFICITY: Highest expression in the outer part of the mantle
CC       rim. Highly expressed in gills, with a much lower expression in the
CC       digestive gland and posterior adductor muscle. Scarcely detectable in
CC       foot. {ECO:0000269|PubMed:31769916}.
CC   -!- BIOTECHNOLOGY: This protein has potential for the detection and control
CC       of certain cancer cells and cells of the immune system, that display
CC       asialo-GM1 (PubMed:33328520). Has potential clinical applications since
CC       it recognizes glycans expressed specifically by the target antigen for
CC       Guillain-Barre syndrome (GM1b), natural killer (NK) cells and basophils
CC       (asialo-GM1) and glioblastoma multiforme (SSEA-4) in vertebrates
CC       (PubMed:31769916). {ECO:0000305|PubMed:31769916,
CC       ECO:0000305|PubMed:33328520}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; MK434191; QBM06340.1; -; mRNA.
DR   PDB; 6LF1; X-ray; 1.70 A; A/B=1-129.
DR   PDB; 6LF2; X-ray; 1.60 A; A/B=1-129.
DR   PDBsum; 6LF1; -.
DR   PDBsum; 6LF2; -.
DR   SMR; A0A646QV53; -.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   InterPro; IPR035992; Ricin_B-like_lectins.
DR   SUPFAM; SSF50370; SSF50370; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Hemagglutinin; Lectin.
FT   CHAIN           1..129
FT                   /note="GM1b/asialo-GM1 oligosaccharide-binding R-type
FT                   lectin"
FT                   /id="PRO_0000453280"
FT   BINDING         21..23
FT                   /ligand="a carbohydrate"
FT                   /ligand_id="ChEBI:CHEBI:16646"
FT                   /evidence="ECO:0000269|PubMed:33328520,
FT                   ECO:0007744|PDB:6LF2"
FT   BINDING         26..28
FT                   /ligand="a carbohydrate"
FT                   /ligand_id="ChEBI:CHEBI:16646"
FT                   /evidence="ECO:0000269|PubMed:33328520,
FT                   ECO:0007744|PDB:6LF2"
FT   BINDING         32
FT                   /ligand="a carbohydrate"
FT                   /ligand_id="ChEBI:CHEBI:16646"
FT                   /evidence="ECO:0000269|PubMed:33328520,
FT                   ECO:0007744|PDB:6LF2"
FT   BINDING         37..40
FT                   /ligand="a carbohydrate"
FT                   /ligand_id="ChEBI:CHEBI:16646"
FT                   /evidence="ECO:0000269|PubMed:33328520,
FT                   ECO:0007744|PDB:6LF2"
FT   MUTAGEN         12
FT                   /note="Q->R: Loss of hemagglutination. Loss of
FT                   homodimerization, but retains saccharide binding; when
FT                   associated with K-126."
FT                   /evidence="ECO:0000269|PubMed:33328520"
FT   MUTAGEN         39
FT                   /note="D->H: Loss of hemagglutination."
FT                   /evidence="ECO:0000269|PubMed:33328520"
FT   MUTAGEN         126
FT                   /note="F->K: Loss of hemagglutination. Loss of
FT                   homodimerization, but retains saccharide binding; when
FT                   associated with R-12."
FT                   /evidence="ECO:0000269|PubMed:33328520"
FT   STRAND          7..13
FT                   /evidence="ECO:0007829|PDB:6LF2"
FT   TURN            14..16
FT                   /evidence="ECO:0007829|PDB:6LF2"
FT   STRAND          19..23
FT                   /evidence="ECO:0007829|PDB:6LF2"
FT   TURN            24..27
FT                   /evidence="ECO:0007829|PDB:6LF2"
FT   STRAND          28..32
FT                   /evidence="ECO:0007829|PDB:6LF2"
FT   HELIX           38..40
FT                   /evidence="ECO:0007829|PDB:6LF2"
FT   STRAND          42..46
FT                   /evidence="ECO:0007829|PDB:6LF2"
FT   STRAND          53..57
FT                   /evidence="ECO:0007829|PDB:6LF2"
FT   STRAND          60..64
FT                   /evidence="ECO:0007829|PDB:6LF2"
FT   STRAND          69..74
FT                   /evidence="ECO:0007829|PDB:6LF2"
FT   HELIX           77..79
FT                   /evidence="ECO:0007829|PDB:6LF2"
FT   STRAND          81..85
FT                   /evidence="ECO:0007829|PDB:6LF2"
FT   STRAND          93..97
FT                   /evidence="ECO:0007829|PDB:6LF2"
FT   TURN            98..100
FT                   /evidence="ECO:0007829|PDB:6LF2"
FT   STRAND          103..107
FT                   /evidence="ECO:0007829|PDB:6LF2"
FT   STRAND          110..116
FT                   /evidence="ECO:0007829|PDB:6LF2"
FT   HELIX           119..121
FT                   /evidence="ECO:0007829|PDB:6LF2"
FT   STRAND          123..127
FT                   /evidence="ECO:0007829|PDB:6LF2"
SQ   SEQUENCE   129 AA;  15047 MW;  149CC6B3A03C7562 CRC64;
     MSSVTIGKCY IQNRENGGRA FYNLGRKDLG IFTGKMYDDQ IWSFQKSDTP GYYTIGRESK
     FLQYNGEQVI MSDIEQDTTL WSLEEVPEDK GFYRLLNKVH KAYLDYNGGD LVANKHQTES
     EKWILFKAY
//
